A carregar...
Immuno-Oncotherapeutic Approaches in Advanced Hepatocellular Carcinoma
Advanced hepatocellular carcinoma has limited treatment options, but there has been extensive growth recently with cabozantinib, regorafenib, lenvatinib, nivolumab, atezolizumab, and bevacizumab, which are some of the treatments that have received FDA approval just over the last three years. Because...
Na minha lista:
| Publicado no: | Vaccines (Basel) |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7563532/ https://ncbi.nlm.nih.gov/pubmed/32784389 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines8030447 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|